Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’
Crossref DOI link: https://doi.org/10.1007/s13300-018-0494-1
Published Online: 2018-09-06
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, Marc
,
Funding for this research was provided by:
Napp Pharmaceuticals
Article History
Received: 7 August 2018
First Online: 6 September 2018